AR080294A1 - Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia - Google Patents

Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia

Info

Publication number
AR080294A1
AR080294A1 ARP110100555A ARP110100555A AR080294A1 AR 080294 A1 AR080294 A1 AR 080294A1 AR P110100555 A ARP110100555 A AR P110100555A AR P110100555 A ARP110100555 A AR P110100555A AR 080294 A1 AR080294 A1 AR 080294A1
Authority
AR
Argentina
Prior art keywords
solubility
administration
magnolia
improve
active compounds
Prior art date
Application number
ARP110100555A
Other languages
English (en)
Inventor
Subramanyam Ravi
Fei Lin
Guofeng Xu
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of AR080294A1 publication Critical patent/AR080294A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/57—Magnoliaceae (Magnolia family)
    • A61K36/575—Magnolia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

Métodos para el mejoramiento de la solubilidad y administracion de uno o más de los ingredientes activos hallados en el extracto de magnolia o uno de sus análogos sintéticos, en una composicion de uso oral. Reivindicacion 1: Una composicion de uso oral caracterizada porque incluye entre 0,05 y 10% en peso de propilenglicol; entre 0,05 y 5% en peso de al menos uno o más de los ingredientes activos hallados en el extracto de magnolia o uno de sus análogos sintéticos, donde al menos uno de los uno o más ingredientes activos es seleccionado a partir del grupo constituido por extracto de magnolia, magnolol, honokiol, tetrahidromagnolol, tetrahidrohonokiol (propilhonokiol), 5,5'-di-n-butil-bifenil-2,2'-diol y una combinacion de dos o más de ellos; y un vehículo oralmente aceptable.
ARP110100555A 2010-02-24 2011-02-24 Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia AR080294A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30766410P 2010-02-24 2010-02-24

Publications (1)

Publication Number Publication Date
AR080294A1 true AR080294A1 (es) 2012-03-28

Family

ID=43768879

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110100555A AR080294A1 (es) 2010-02-24 2011-02-24 Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia

Country Status (15)

Country Link
US (1) US9801940B2 (es)
EP (1) EP2523676B1 (es)
JP (1) JP5665888B2 (es)
CN (1) CN102762219B (es)
AR (1) AR080294A1 (es)
AU (1) AU2011220789B2 (es)
BR (1) BR112012019997A2 (es)
CA (1) CA2788423A1 (es)
CO (1) CO6592076A2 (es)
MX (1) MX2012009139A (es)
RU (2) RU2015114797A (es)
SG (1) SG183117A1 (es)
TW (1) TWI422382B (es)
WO (1) WO2011106492A1 (es)
ZA (1) ZA201206068B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI459957B (zh) * 2010-02-24 2014-11-11 Colgate Palmolive Co 口腔保健組成物
RU2549543C2 (ru) 2010-12-21 2015-04-27 Колгейт-Палмолив Компани Галогенированные бифенолы в качестве антибактериальных средств
AU2011376338B2 (en) * 2011-09-08 2015-08-27 Colgate-Palmolive Company Oral and skin care compositions based on a 3, 3 ' - dialkyl - 1, 1 ' - biphenyl - 2, 2 ' - diol or a 3, 3 ' -dialkenyl- 1, 1 ' -biphenyl- 2, 2 ' -diol
WO2013081626A1 (en) * 2011-12-02 2013-06-06 Colgate-Palmolive Company Oral care composition comprising isobutyl magnolol
CA2856823A1 (en) * 2011-12-02 2013-06-06 Colgate-Palmolive Company Oral care compositions comprising n-butyl magnolol and isobutyl magnolol
EP2790650B1 (en) 2011-12-15 2017-05-24 Colgate-Palmolive Company Solubilized magnolol analogs
BR112014014609B1 (pt) * 2011-12-15 2018-06-05 Colgate-Palmolive Company Composição compreendendo análogos de magnolol solubilizados.
MX341440B (es) 2011-12-15 2016-08-18 Colgate Palmolive Co Analogos de magnolol solubilizados.
US9045397B2 (en) 2011-12-20 2015-06-02 Colgate-Palmolive Company Processes for making magnolol analogs
US9000231B2 (en) 2011-12-20 2015-04-07 Colgate-Palmolive Company Processes for making magnolol and derivatives thereof
MX346214B (es) * 2012-03-02 2017-03-10 Colgate Palmolive Co Composiciones para el cuidado oral.
EP2948220B1 (en) 2013-01-23 2018-07-04 Colgate-Palmolive Company Processes for making magnolol derivatives
WO2014131191A1 (en) * 2013-03-01 2014-09-04 Johnson & Johnson Consumer Companies, Inc. A composition containing honokiol and/or magnolol and uses thereof
CN107847427B (zh) * 2015-07-14 2021-08-06 Wm.雷格利Jr.公司 作为用于从口腔优先去除革兰氏阴性菌的疏水配体的木兰树皮提取物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0176015B1 (ko) 1996-03-26 1999-03-20 서치영 치주질환 예방 및 치료제 조성물
WO2001082922A1 (en) * 2000-04-27 2001-11-08 The Procter & Gamble Company Oral compositions comprising polyphenol herbal extracts
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
US6544409B2 (en) 2001-05-16 2003-04-08 Petroleo Brasileiro S.A. - Petrobras Process for the catalytic oxidation of sulfur, nitrogen and unsaturated compounds from hydrocarbon streams
CN1147286C (zh) * 2001-07-18 2004-04-28 广州美晨股份有限公司 一种中药牙膏
US7347985B2 (en) * 2002-06-25 2008-03-25 Wm. Wrigley Jr. Company Breath freshening and oral cleansing product with magnolia bark extract
CN102008000A (zh) * 2002-06-25 2011-04-13 Wm.雷格利Jr.公司 含有厚朴提取物的口气清新和口腔清洁产品
US7632525B2 (en) * 2002-06-25 2009-12-15 Wm. Wrigley Jr. Company Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents
US20060127329A1 (en) 2004-12-10 2006-06-15 Colgate-Palmolive Company Tartar control oral care composition containing extract of magnolia
US8900644B2 (en) * 2004-12-22 2014-12-02 Colgate-Palmolive Company Oral care compositions containing compounds from magnolia and hops extracts
US20060140885A1 (en) 2004-12-29 2006-06-29 Abdul Gaffar Method of reducing oral tissue inflammation using magnolia extract
CN101132806A (zh) * 2004-12-29 2008-02-27 高露洁-棕榄公司 使用木兰提取物减少口腔组织炎症的方法
US8071077B2 (en) * 2004-12-29 2011-12-06 Colgate-Palmolive Company Oral compositions containing biphenol antibacterial compounds
JP4757911B2 (ja) * 2005-05-30 2011-08-24 コリア インスティテュート オブ オリエンタル メディシン マグノリアの皮質又はマグノリアの根からのマグノロールの大量分離方法
WO2008006582A1 (en) * 2006-07-14 2008-01-17 Dsm Ip Assets B.V. Compositions comprising magnolol or honokiol and other active agents for the treatment of inflammatory diseases
CA2701031A1 (en) 2007-10-01 2009-04-09 Colgate-Palmolive Company Oral compositions containing botanical extracts

Also Published As

Publication number Publication date
EP2523676A1 (en) 2012-11-21
RU2012140474A (ru) 2014-03-27
US9801940B2 (en) 2017-10-31
RU2552322C2 (ru) 2015-06-10
JP2013520517A (ja) 2013-06-06
AU2011220789A1 (en) 2012-08-23
BR112012019997A2 (pt) 2019-09-24
AU2011220789B2 (en) 2013-07-18
CA2788423A1 (en) 2011-09-01
SG183117A1 (en) 2012-09-27
RU2015114797A (ru) 2015-09-20
US20120294812A1 (en) 2012-11-22
CN102762219A (zh) 2012-10-31
WO2011106492A1 (en) 2011-09-01
MX2012009139A (es) 2012-09-21
CO6592076A2 (es) 2013-01-02
JP5665888B2 (ja) 2015-02-04
TW201204376A (en) 2012-02-01
ZA201206068B (en) 2015-04-29
CN102762219B (zh) 2016-05-04
TWI422382B (zh) 2014-01-11
EP2523676B1 (en) 2016-04-20

Similar Documents

Publication Publication Date Title
AR080294A1 (es) Composiciones dirigidas a mejorar la solubilidad y administracion de los compuestos activos de magnolia
AR080295A1 (es) Composiciones para el cuidado bucal y metodos de tratamiento
AR093244A1 (es) Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2
GT201400136A (es) Compuestos y métodos de benzaldehído substituído para su uso en incrementar la oxigenación de los tejidos
CU20140068A7 (es) Triazolopiridinas sustituidas
AR082686A1 (es) Adyuvantes de vacuna que direccionan a los adyuvantes de anticuerpos directamente hacia las celulas presentadoras de antigenos
CL2008002228A1 (es) Compuestos derivados de imidazopiridinonas, agonista de tlr7; procedimiento de preparacion; compuestos intermediarios; composiicon farmaceutica que los comprende; y uso en infecciones virales, bacterianas y fungicas.
CU20120171A7 (es) Triazolopiridinas sustituidas
DOP2011000402A (es) Composicion farmaceutica para la anticoncepcion de emergencia
BR112016010080A8 (pt) compostos de pirazolopirimidina, composição farmacêutica e seu uso
ECSP13013011A (es) Triazolopiridinas
CL2017000293A1 (es) Compuestos derivados de benzofurano sustituido en posición 6 por un radical que contiene boro; composición farmacéutica que los comprende; uso en el tratamiento de la hepatitis c (divisional del cl 393-2014)
BR112014002594A2 (pt) uso de diésteres de isossorbida como espessantes
ECSP12012031A (es) Composición farmacéutica que comprende oligopéptidos
EA201490222A1 (ru) Комбинированные составы на основе дарунавира
AR083769A1 (es) Formulaciones orales que comprenden polietilenglicol
CO2017007057A2 (es) Vacuna contra la fiebre aftosa
BR112014002570A2 (pt) uso de monoésteres de isossorbida como espessantes
ECSP10010078A (es) Co-cristales de pirimetanilo y ditianona
MY163476A (en) Oral care compositions
CR11755A (es) Dronedarona para la prevencion de la cardioversion
ES2648190T3 (es) Compuestos para su uso en el tratamiento de la filariasis
BR112015014180A8 (pt) composições de gel
CL2011003355A1 (es) Compuestos derivados de alcoxi-carbonil-amino-alquinil-adenosina ; composición farmacéutica que los comprende; uso del compuesto en la preparación de un medicamento útil para tratar enfermedades autoinmunes, inflamatorias, alérgicas, infecciosas entre otras.
CL2014000754A1 (es) Compuestos aldehidos cicloalcanicos; procedimiento de preparacion; composicion que los comprende ademas de al menos otra sustancia odorante; su uso en composiciones de perfumeria, composiciones topicas cosmeticas o tambien productos de limpieza.

Legal Events

Date Code Title Description
FB Suspension of granting procedure